Ja. Granchelli et al., ENHANCED SENSITIVITY OF MDX MICE TO INTRAMUSCULAR INJECTION, Research communications in chemical pathology and pharmacology, 84(3), 1994, pp. 351-362
Species-specific differences in the inflammatory response, specificall
y with regard to mast cells, have been proposed to explain the phenoty
pic variation among dystrophin-deficient humans, and mdx mice (Gorospe
et al., 1994). To test this hypothesis we have intramuscularly inject
ed a mast cell secretogogue into both dystrophin-negative mdr and dyst
rophin-positive normal mice. Mast cell activity was determined by meas
uring the activity of mast cell tryptase, while creatine kinase activi
ty was used to determine the course of muscle damage in vivo. Area of
damage around the injection site was measured at autopsy, and used as
an indication of relative sensitivity to the secretogogue effect of co
mpound 48/80. Mdr mice exhibited more damage in response to intramuscu
lar injection than normal control mice. In addition, mdx mice showed a
substantial increase in plasma tryptase activity, followed by a large
increase in muscle creatine kinase activity. On the other hand, dystr
ophin-positive normal controls injected with 48/80 liberated little CK
or tryptase activity. These results are consistent with the hypothesi
s that species-specific differences in mast cell activity, or sensitiv
ity to mast cell products could account for the variation in pathology
seen in dystrophin-deficient animals.